Adam Koppel - 29 Dec 2024 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Director
Signature
/s /Kristian Humer, Attorney-in-Fact for Adam Koppel
Issuer symbol
FHTX
Transactions as of
29 Dec 2024
Transactions value $
$0
Form type
4
Filing time
30 Dec 2024, 07:54:56
Previous filing
05 Aug 2024
SEC
View on sec.gov

Adam Koppel is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

The Reporting Person resigned from the Board of Directors of Foghorn Therapeutics Inc., effective December 29, 2024. This Form 4 is being filed solely as a voluntary exit Form 4 indicating that no further reporting will be required of the Reporting Person.